The following Test Facilities have been inspected by the Swiss Monitoring Authorities. It was found that they were operating in compliance with the GLP Principles at the time they were inspected. The Facilities are in the compliance monitoring programme of the authorities.
According to article 6 paragraph 2 of the Ordinance on Good Laboratory Practice (OGLP), the Test Facilites are re-inspected every two to three years on a routine basis.
The list is regularly updated according to article 14 OGLP. In case of doubt concerning the actual situation of a particular Facility please contact the notification authority for chemicals.
| Test Facilities | Last Inspect. |
Areas of Expertise* |
|---|---|---|
| AnaPath Services GmbH 4410 Liestal AnaPath Services GmbH 4625 Oberbuchsiten |
Aug 2020 | OTH (histopathology) |
| AO Research Institute Davos 7270 Davos Platz |
May 2021 | OTH (biocompatibility and efficacy studies with medical devices and pharmaceuticals) |
| Arcadis Schweiz AG 8952 Schlieren |
May 2022 | ECT, ENF, PCT |
| BiognoSYS AG Wagistrasse 21 8952 Schlieren |
Aug 2021 | OTH (proteomics) |
| Bracco Suisse SA 1228 Plan-les-Ouates, Geneva |
Mar 2021 | ACC, TOX |
| B'SYS GmbH 4108 Witterswil |
Jul 2020 | OTH (Electrophysiology) |
| Celerion Switzerland AG 8320 Fehraltorf |
Sep 2021 | ACC |
| F.Hoffmann-La Roche Ltd. Pharma Research 4070 Basel |
Jan 2020 | ACC, MUT, OTH (pathology review) |
| Givaudan SA Ecotoxicology 1214 Vernier |
May 2021 | ENF, PCT |
| Idorsia Ltd.4123 Allschwil | Jun 2021 | ACC |
| Innovative Environmental Services (IES) Ltd. 4108 Witterswil |
Jul 2021 | PCT, ECT, ENF, RES, ACC, OTH (in vitro metabolism/dermal penetration) |
| Institute for Biopharmaceutical Research (IBR), Inc. 9548 Matzingen |
July 2019 | ACC, OTH (pharmacokinetics, immunological testing) |
| Integrated Biologix GmbH 4051 Basel |
Jan 2022 | OTH (pathology review) |
| Intertek (Schweiz) AG TechCenter Reinach 4153 Reinach |
Mar 2022 | PCT, ACC |
| LKC Switzerland Ltd 4414 Füllinsdorf |
Sep 2020 | OTH (study direction of multisite residue studies) |
| MSRU Vetsuisse Faculty Zürich 8057 Zürich |
Oct 2019 | TOX, OTH (biocompability and efficacy with medical devices and pharmaceuticals) |
| Novartis Pharma AG PCS/ Project Pathology 4002 Basel |
Jan 2022 | OTH (pathology review) |
| Philip Morris Products S.A. Research and Development PMI Product Testing 2000 Neuchâtel |
May 2021 | MUT, OTH (in vitro toxicity, proteomics) |
| Swiss BioQuant AG 4153 Reinach |
Nov 2021 | ACC |
| Syngenta Crop Protection AG GLP Testing Facility WMU 4333 Münchwilen |
Nov 2019 | ACC, PCT |
| SGS Analytics Switzerland AG 4127 Birsfelden |
May 2022 | ACC, OTH (in vitro cytotoxicity) |
Areas of Expertise:
PCT Physical-chemical testing
TOX Toxicity studies
MUT Mutagenicity studies
ECT Environmental toxicity studies on aquatic and terrestrial organisms
ENF Studies on behaviour in water, soil, and air; bioaccumulation
RES Residue studies
EMN Studies on effects on mesocosms and natural ecosystems
ACC Analytical and clinical chemistry testing
OTH Other studies, specify
Last modification 29.01.2019
